TABLE 1.
Domain | Metric Example | Clinical Conclusion |
---|---|---|
Function | SPPB26 | Impaired SPPB is associated with a twofold higher risk of death compared with those with a normal physical performance among populations with leukemia27 |
TUG | Poor mobility by TUG predicts early mortality among cancer populations | |
Handgrip strength28 | Grip strength is an accurate and consistent predictor of all causes of mortality in middle-aged and elderly persons (RR, 0.89)29 | |
Brief Fatigue Inventory30 | Fatigue strongly correlates with depression and is highly variable post-transplant39 | |
ADL/IADL | Deficits in ADL, combined with age and comorbidities among patients with MM, resulted in notable survival differences in patients21 | |
Psychiatric | HADS31 | Psychiatric morbidity results in a significantly longer length of hospital stay and influences recovery post-transplant32 |
Social | MOS Social Support Survey31 | Social isolation and loneliness predict disease outcome and results in substantial impairment in psychologic and physical well-being33 |
Social support structure impacts clinical outcomes and quality of life post-transplant.34,35 | ||
3MS | Cognitive impairment demonstrates the greatest likelihood for mortality among older adults with leukemia27 | |
Attention deficits persist for up to a year following myeloma transplant36 | ||
Nutrition | MNA | Impaired nutritional status independently predicts early death in patients with newly diagnosed cancer at age 65 or older (OR, 2.77). |
Comorbidities | Comorbidity calculator38 | HCT-CI predicts nonrelapse mortality and survival in MM37,38 |
Abbreviations: SPPB, Short Physical Performance Battery; TUG, Timed Up and Go Test; ADL, activities of daily living; IADL, instrumental activities of daily living; HADS, Hospital Anxiety and Depression Scale; MOS, Medical Outcomes Study; 3MS, Modified Mini Mental State; MNA, Mini-Nutritional Assessment; RR, relative risk; MM, multiple myeloma; OR, odds ratio; HCT-CI, hematopoietic cell transplantation comorbidity index.